Avanir Pharmaceuticals Inc (NASDAQ:AVNR) was upgraded by Jefferson Research from a “sell” rating to a “hold” rating in a research note issued. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock opened at $3.82 in last session, and closed at $4.29, while the day range of AVNR stock is $3.64 – $4.39. The stock showed a positive weekly performance of 5.67%.
Mylan Inc (NASDAQ:MYL) this week announced that its subsidiary Agila Specialties Private Limited is conducting a voluntary nationwide recall in the United States of the hospital/user-level certain lots of Etomidate Injection which is used for induction of general anesthesia. Mylan Inc (NASDAQ:MYL) stock opened at $51.17, in last session and closed at $51.42, by gaining 0.18%. The 52 week range of MYL is $27.66 – $52.44. Company’s market capitalization is $19.68billion.
Last week, notorious proxy rebel Carl Icahn touted a victory for his activist investing strategy, taking credit for the management changes that ultimately drew Actavis plc (NYSE:ACT) as a buyer. And as it turns out, Forest Laboratories ($FRX) drew more than one interested buyer, with deal-hungry AstraZeneca ($AZN) making its own abortive pickup approach. Actavis plc (NYSE:ACT) stock advanced 1.00% and finished the last session at $227.26. The EPS of the stock remained -4.36. Company’s market capitalization is $30.11billion.
Zoetis Inc (NYSE:ZTS) has announced the return of its industry support program for youth involved in agriculture and veterinary medicine. Zoetis Inc (NYSE:ZTS) stock opened the session at $30.04, and closed the session at $30.40. The 52 week range of the ZTS stock remained $28.77 – $35.42 and the day range was $30.00 – $30.45.